Promise and challenges with the use of mobile applications to support and improve patient care: An industry perspective

Clinical Pharmacology and Therapeutics

Volumn 95, Issue 5, 2014, Pages 469-471

  Bucklen, K W ^a   Abbott, B M ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; MEDICAL DEVICE; MEDICATION COMPLIANCE; MOBILE APPLICATION; MOTIVATION; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; REMINDER SYSTEM; REVIEW;

CELLULAR PHONE; DELIVERY OF HEALTH CARE; HUMANS; INDIVIDUALIZED MEDICINE; INDUSTRY; MEDICAL DEVICE LEGISLATION; MOBILE APPLICATIONS; PATIENT CARE; PHYSICIANS; SOFTWARE; TIME FACTORS;

EID: 84899012099     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2014.34     Document Type: Review

References (3)

1. Kamerow, D. Regulating medical apps: which ones and how much? BMJ 347, f6009 〈http://www.bmj.com/content/347/bmj.f6009〉 (8 October 2013).
2. Dayer, L., Heldenbrand, S., Anderson, P., Gubbins, P.O. & Martin, B.C. Smartphone medication adherence apps: potential benefits to patients and providers. J. Am. Pharm. Assoc. 53, 172-181 (2013).
3. US Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation and Research. Mobile medical applications: guidance for industry and Food and Drug Administration staff 〈http://www. fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/UCM263366.pdf〉 (25 September 2013).